Coverage from the first of 3 Peer Exchangeâ„¢ discussions from the Diabetes Stakeholders Summit.
Peer Exchange: Diabetes Stakeholders Summit
From Unexpected CV Benefits to Potential in Heart Failure: Insights and Outlook for SGLT2 Inhibitors
Coverage from the first of 3 Peer Exchangeâ„¢ discussions from the Diabetes Stakeholders Summit.
A study presented at the 2017 Scientific Session of the American College of Cardiology uses claims data to examine whether SGLT2 inhibitors offer a protective benefit against heart failure.
Coverage from the first of 3 Peer Exchangeâ„¢ discussions from the Diabetes Stakeholders Summit.
Advertisement
Advertisement
Trending on AJMC
1
GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH
2
$20 Billion National Strategy Aims to Close the Women's Health Gap
3
5 Novel FDA Approvals That Signal a Shift Toward Convenience-Driven Care
4
Smartwatch Study Links Midlife to Rising Nighttime Awakenings in Women
5